However, none of these studies have included in vivo experiments to confirm the in vitro findings on the proliferation and migration/invasion of NDRG1-high vs. NDRG1-low cells, and only two studies have reported outcomes from patients with breast cancer. The gene discussed is NDRG1; the disease is breast cancer.